Home » Topics » Ocular, BioWorld Science

Ocular, BioWorld Science
RSS

Phase II data reported for RP-101 in moderate-to-severe DED

March 13, 2020

First-in-human data for AAV8-coRPGR gene therapy

March 13, 2020

CANBERRA trial to evaluate RG-7774 in diabetic retinopathy

March 12, 2020

Santen and Tracon discontinue development of DE-122 for wet AMD following phase IIa results

March 10, 2020

Kala reports promising topline data from STRIDE 3 study of Eysuvis in dry eye disease

March 10, 2020

GBV-6249-192 demonstrates good preclinical results for treating primary open-angle glaucoma

March 4, 2020

Complement factor D inhibitors identified at Achillion

March 4, 2020

Novel RGC-specific AAV7m8-SIRT1 gene therapy shows neuroprotective effects in vivo

March 2, 2020

Clene announces interim blinded data from phase II study of CNM-Au8 for vision impairment in MS

Feb. 28, 2020

Boehringer Ingelheim Pharma patents KLKB1 inhibitors

Feb. 28, 2020

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan. 28, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for January 28, 2025
New drugs with the same old resistance tricks?
BioWorld
According to the World Health Organization (WHO), multidrug-resistant pathogens caused over 1.27 million deaths worldwide in 2020. And figures are rising, with...
OS Therapies heading to FDA with positive osteosarcoma data
BioWorld
With positive data in hand from its phase IIb trial testing immunotherapy candidate OST-HER2 in osteosarcoma, OS Therapies Inc. anticipates a regulatory filing...
Vilastobart set apart? Xilio phase II combo performs in CRC
BioWorld
“The [colorectal cancer field is moving, and thankfully it’s moving quickly,” said Marwan Fakih, gastrointestinal specialist at City of Hope, speaking about...